These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 37058530)

  • 1. CRISPR-Cas effector specificity and cleavage site determine phage escape outcomes.
    Schelling MA; Nguyen GT; Sashital DG
    PLoS Biol; 2023 Apr; 21(4):e3002065. PubMed ID: 37058530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of target specificity of CRISPR-Cas12a by using a chimeric DNA-RNA guide.
    Kim H; Lee WJ; Oh Y; Kang SH; Hur JK; Lee H; Song W; Lim KS; Park YH; Song BS; Jin YB; Jun BH; Jung C; Lee DS; Kim SU; Lee SH
    Nucleic Acids Res; 2020 Sep; 48(15):8601-8616. PubMed ID: 32687187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Covalent Modifications of the Bacteriophage Genome Confer a Degree of Resistance to Bacterial CRISPR Systems.
    Liu Y; Dai L; Dong J; Chen C; Zhu J; Rao VB; Tao P
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32938767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR-Cas12a has widespread off-target and dsDNA-nicking effects.
    Murugan K; Seetharam AS; Severin AJ; Sashital DG
    J Biol Chem; 2020 Apr; 295(17):5538-5553. PubMed ID: 32161115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR-Cas12a exhibits metal-dependent specificity switching.
    Nguyen GT; Schelling MA; Buscher KA; Sritharan A; Sashital DG
    bioRxiv; 2024 Jan; ():. PubMed ID: 38076861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primed CRISPR-Cas Adaptation and Impaired Phage Adsorption in Streptococcus mutans.
    Mosterd C; Moineau S
    mSphere; 2021 May; 6(3):. PubMed ID: 34011685
    [No Abstract]   [Full Text] [Related]  

  • 7. A DNA unwinding equilibrium serves as a checkpoint for CRISPR-Cas12a target discrimination.
    Singh J; Liu KG; Allen A; Jiang W; Qin PZ
    Nucleic Acids Res; 2023 Sep; 51(16):8730-8743. PubMed ID: 37522352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Different Target Sequences on Type III CRISPR-Cas Immunity.
    Maniv I; Jiang W; Bikard D; Marraffini LA
    J Bacteriol; 2016 Jan; 198(6):941-50. PubMed ID: 26755632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimized protocols for the characterization of Cas12a activities.
    Martin L; Rostami S; Rajan R
    Methods Enzymol; 2023; 679():97-129. PubMed ID: 36682874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteriophage T4 Escapes CRISPR Attack by Minihomology Recombination and Repair.
    Wu X; Zhu J; Tao P; Rao VB
    mBio; 2021 Jun; 12(3):e0136121. PubMed ID: 34154416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering of Cas12a nuclease variants with enhanced genome-editing specificity.
    Chen P; Zhou J; Liu H; Zhou E; He B; Wu Y; Wang H; Sun Z; Paek C; Lei J; Chen Y; Zhang X; Yin L
    PLoS Biol; 2024 Mar; 22(3):e3002514. PubMed ID: 38483978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Basis for the Inhibition of CRISPR-Cas12a by Anti-CRISPR Proteins.
    Zhang H; Li Z; Daczkowski CM; Gabel C; Mesecar AD; Chang L
    Cell Host Microbe; 2019 Jun; 25(6):815-826.e4. PubMed ID: 31155345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic analysis of CRISPR-Cas9 mismatch tolerance reveals low levels of off-target activity.
    Anderson EM; Haupt A; Schiel JA; Chou E; Machado HB; Strezoska Ž; Lenger S; McClelland S; Birmingham A; Vermeulen A; Smith Av
    J Biotechnol; 2015 Oct; 211():56-65. PubMed ID: 26189696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional Analysis of Bacteriophage Immunity through a Type I-E CRISPR-Cas System in Vibrio cholerae and Its Application in Bacteriophage Genome Engineering.
    Box AM; McGuffie MJ; O'Hara BJ; Seed KD
    J Bacteriol; 2016 Feb; 198(3):578-90. PubMed ID: 26598368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A functional type II-A CRISPR-Cas system from Listeria enables efficient genome editing of large non-integrating bacteriophage.
    Hupfeld M; Trasanidou D; Ramazzini L; Klumpp J; Loessner MJ; Kilcher S
    Nucleic Acids Res; 2018 Jul; 46(13):6920-6933. PubMed ID: 30053228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degenerate target sites mediate rapid primed CRISPR adaptation.
    Fineran PC; Gerritzen MJ; Suárez-Diez M; Künne T; Boekhorst J; van Hijum SA; Staals RH; Brouns SJ
    Proc Natl Acad Sci U S A; 2014 Apr; 111(16):E1629-38. PubMed ID: 24711427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple Origins and Specific Evolution of CRISPR/Cas9 Systems in Minimal Bacteria (
    Ipoutcha T; Tsarmpopoulos I; Talenton V; Gaspin C; Moisan A; Walker CA; Brownlie J; Blanchard A; Thebault P; Sirand-Pugnet P
    Front Microbiol; 2019; 10():2701. PubMed ID: 31824468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for mismatch surveillance by CRISPR-Cas9.
    Bravo JPK; Liu MS; Hibshman GN; Dangerfield TL; Jung K; McCool RS; Johnson KA; Taylor DW
    Nature; 2022 Mar; 603(7900):343-347. PubMed ID: 35236982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Off-Target Effect of CRISPR-Cas12a System toward Insertions and Deletions between Target DNA and crRNA Sequences.
    Zhang W; Shi R; Dong K; Hu H; Shu W; Mu Y; Yan B; Li L; Xiao X; Wang H
    Anal Chem; 2022 Jun; 94(24):8596-8604. PubMed ID: 35670376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA interference is controlled by R-loop length in a type I-F1 CRISPR-Cas system.
    Tuminauskaite D; Norkunaite D; Fiodorovaite M; Tumas S; Songailiene I; Tamulaitiene G; Sinkunas T
    BMC Biol; 2020 Jun; 18(1):65. PubMed ID: 32539804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.